These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37138633)

  • 1. Growth differentiation factor 11 delivered by dairy
    Américo MF; Freitas ADS; da Silva TF; de Jesus LCL; Barroso FAL; Campos GM; Santos RCV; Gomes GC; Assis R; Ferreira Ê; Mancha-Agresti P; Laguna JG; Chatel JM; Carvalho RDO; Azevedo V
    Front Microbiol; 2023; 14():1157544. PubMed ID: 37138633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.
    Carvalho RD; Breyner N; Menezes-Garcia Z; Rodrigues NM; Lemos L; Maioli TU; da Gloria Souza D; Carmona D; de Faria AM; Langella P; Chatel JM; Bermúdez-Humarán LG; Figueiredo HC; Azevedo V; de Azevedo MS
    Microb Cell Fact; 2017 Feb; 16(1):27. PubMed ID: 28193209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant probiotic
    Laguna JG; Freitas ADS; Barroso FAL; De Jesus LCL; De Vasconcelos OAGG; Quaresma LS; Américo MF; Campos GM; Glória RA; Dutra JDCF; Da Silva TF; Vital KD; Fernandes SO; Souza RO; Martins FDS; Ferreira E; Santos TM; Birbrair A; De Oliveira MFA; Faria AMC; Carvalho RDO; Venanzi FM; Le Loir Y; Jan G; Guédon É; Azevedo VAC
    Front Microbiol; 2024; 15():1309160. PubMed ID: 38680913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP.
    Carvalho R; Vaz A; Pereira FL; Dorella F; Aguiar E; Chatel JM; Bermudez L; Langella P; Fernandes G; Figueiredo H; Goes-Neto A; Azevedo V
    Sci Rep; 2018 Oct; 8(1):15072. PubMed ID: 30305667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic synbiotic containing fructooligosaccharides and Lactobacillus delbrueckii CIDCA 133 alleviates chemotherapy-induced intestinal mucositis in mice.
    Tavares LM; de Jesus LCL; Batista VL; Barroso FAL; Dos Santos Freitas A; Campos GM; Américo MF; da Silva TF; Coelho-Rocha ND; Belo GA; Drumond MM; Mancha-Agresti P; Vital KD; Fernandes SOA; Cardoso VN; Birbrair A; Ferreira E; Martins FS; Laguna JG; Azevedo V
    World J Microbiol Biotechnol; 2023 Jun; 39(9):235. PubMed ID: 37365380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intake of
    Barroso FAL; de Jesus LCL; de Castro CP; Batista VL; Ferreira Ê; Fernandes RS; de Barros ALB; Leclerq SY; Azevedo V; Mancha-Agresti P; Drumond MM
    Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33466324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
    Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
    Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Barroso FAL; de Jesus LCL; da Silva TF; Batista VL; Laguna J; Coelho-Rocha ND; Vital KD; Fernandes SOA; Cardoso VN; Ferreira E; Martins FS; Drumond MM; Mancha-Agresti P; Birbrair A; Barh D; Azevedo V
    Front Microbiol; 2022; 13():858036. PubMed ID: 35558121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress.
    Zeeshan M; Atiq A; Ain QU; Ali J; Khan S; Ali H
    Inflammopharmacology; 2021 Oct; 29(5):1539-1553. PubMed ID: 34420176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wumei pills attenuates 5-fluorouracil-induced intestinal mucositis through Toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-κB pathway and microbiota regulation.
    Lu DX; Liu F; Wu H; Liu HX; Chen BY; Yan J; Lu Y; Sun ZG
    World J Gastroenterol; 2022 Aug; 28(32):4574-4599. PubMed ID: 36157934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats.
    Tang Y; Wu Y; Huang Z; Dong W; Deng Y; Wang F; Li M; Yuan J
    Nutrition; 2017 Jan; 33():96-104. PubMed ID: 27427511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging.
    Chang CT; Ho TY; Lin H; Liang JA; Huang HC; Li CC; Lo HY; Wu SL; Huang YF; Hsiang CY
    PLoS One; 2012; 7(3):e31808. PubMed ID: 22412841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraprobiotics and Postbiotics of
    Batista VL; De Jesus LCL; Tavares LM; Barroso FLA; Fernandes LJDS; Freitas ADS; Americo MF; Drumond MM; Mancha-Agresti P; Ferreira E; Laguna JG; Alcantara LCJ; Azevedo V
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4.
    Soares PM; Mota JM; Souza EP; Justino PF; Franco AX; Cunha FQ; Ribeiro RA; Souza MH
    Cytokine; 2013 Jan; 61(1):46-9. PubMed ID: 23107827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
    Justino PFC; Franco AX; Pontier-Bres R; Monteiro CES; Barbosa ALR; Souza MHLP; Czerucka D; Soares PMG
    Cytokine; 2020 Jan; 125():154791. PubMed ID: 31401369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mild moxibustion on intestinal microbiome and NLRP3 inflammasome in rats with 5-fluorouracil-induced intestinal mucositis.
    Li BR; Shao SY; Yuan L; Jia R; Sun J; Ji Q; Sui H; Zhou LH; Zhang Y; Liu H; Li Q; Wang Y; Zhang BM
    J Integr Med; 2021 Mar; 19(2):144-157. PubMed ID: 33353843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Chain Fatty Acids Attenuate 5-Fluorouracil-Induced THP-1 Cell Inflammation through Inhibiting NF-κB/NLRP3 Signaling via Glycerolphospholipid and Sphingolipid Metabolism.
    Zhang Y; Xi Y; Yang C; Gong W; Wang C; Wu L; Wang D
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
    Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
    Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Probiotic Properties of Novel Brazilian Lactiplantibacillus plantarum Strains.
    Coelho-Rocha ND; de Jesus LCL; Barroso FAL; da Silva TF; Ferreira E; Gonçalves JE; Dos Santos Martins F; de Oliveira Carvalho RD; Barh D; Azevedo VAC
    Probiotics Antimicrob Proteins; 2023 Feb; 15(1):160-174. PubMed ID: 36028786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.